Warner Bros Discovery Inc
NASDAQ:WBD

Watchlist Manager
Warner Bros Discovery Inc Logo
Warner Bros Discovery Inc
NASDAQ:WBD
Watchlist
Price: 9.18 USD -0.54% Market Closed
Market Cap: 22.7B USD

Warner Bros Discovery Inc
Investor Relations

Warner Bros Discovery Inc. emerges as a dynamic powerhouse in the media and entertainment industry, representing the fusion of two iconic names: WarnerMedia and Discovery, Inc. This corporate merger, consummated in 2022, was orchestrated to blend WarnerMedia's strength in film and television production with Discovery's expertise in non-fiction and international content. The combined entity leverages an extensive portfolio that includes beloved brands such as HBO, Warner Bros., CNN, and the Discovery Channel. This diverse range of assets positions Warner Bros Discovery to thrive in an ever-evolving media landscape where streaming services, traditional television, and cinematic experiences blend seamlessly. The strategic alignment allows Warner Bros Discovery to create, distribute, and monetize content across multiple platforms, catering to global audiences.

In monetizing its vast array of content, Warner Bros Discovery employs a multifaceted approach. The company generates revenue through various streams, such as direct-to-consumer subscriptions, advertising, content licensing, and theatrical distribution. Platforms like HBO Max and Discovery+ serve as integral components of its digital strategy, where subscribers pay to access a vast library of films, series, documentaries, and original programming. In parallel, its traditional cable networks and production units capitalize on advertising revenue and syndication deals. The theatrical release of films provides another significant income stream, bolstered by a storied history of blockbuster hits. Through these revenue channels, Warner Bros Discovery not only captures diverse market segments but also adapts to shifts in consumer behavior, ensuring its place at the forefront of the entertainment industry.

Show more
Loading

Earnings Calls

2025 Q1
Apr 24, 2025
Show Transcript
Previous
Next
Hypera Pharma Sees Sellout Growth and Optimizes Working Capital
2025 Q1
Apr 24, 2025

In Q1 2025, Hypera Pharma's sellout grew by 7%, achieving a 21% increase in the institutional market and 6% in retail. Despite this, net revenue declined by 40% to BRL 1.08 billion due to a working capital optimization strategy. The company anticipates an 8% growth in sellout for the year, focusing on major product launches, while maintaining operational cash flow at a record BRL 560 million. Marketing expenses rose by 40%, contributing to a negative EBITDA of BRL 149 million, but margins are expected to rebound as operations normalize. Future guidance includes EBITDA margins returning to 35% and gross margins exceeding 60%.

Show Full Analysis

Management

Mr. David M. Zaslav
President, CEO & Director
No Bio Available
Dr. Gunnar Wiedenfels Ph.D.
Senior EVP & CFO
No Bio Available
Mr. Bruce L. Campbell
Chief Revenue & Strategy Officer
No Bio Available
Mr. Jean-Briac Perrette
President and CEO of Global Streaming & Games
No Bio Available
Mr. Gerhard Zeiler
President of International
No Bio Available
Ms. Lori C. Locke
Chief Accounting Officer & Executive VP
No Bio Available
Mr. Avi Saxena
Chief Technology Officer
No Bio Available
Mr. Dave Duvall
Chief Information Officer
No Bio Available
Mr. Robert Lane Gibbs
Chief Communications & Public Affairs Officer
No Bio Available
Ms. Jennifer Remling
Chief People & Culture Officer
No Bio Available

Contacts

Address
NEW YORK
New York City
230 Park Avenue South
Contacts
+12125485555
wbd.com